Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 12, 2022
Advarra announced that the Advarra Gene Therapy Ready™ site network has grown to over 1,000 registered research sites. This reinforces Advarra's position as the world's largest administrator of institutional biosafety committees (IBCs) and the most ...
read more
Wednesday, October 12, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, has completed another expansion phase at its viral vector process development and cGMP vector ...
read more
Wednesday, October 12, 2022
PharmAla Biotech has retained Clerkenwell Health, a UK-based Contract Research Organization, to assist PharmAla in regulatory proceedings with both the FDA and the UK Medicines and Health Regulatory Authority (MHRA).
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Tuesday, October 11, 2022
CSafe and BioLife Solutions, Inc. announced a new partnership to provide a combined global service network to support CGT products, with a focus on enhanced reliability, security and quality.
read more
Tuesday, October 11, 2022
Mikart, LLC to collaborate with Nano PharmaSolutions, who has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).
read more
Tuesday, October 11, 2022
Ginkgo Bioworks is collaborating with Merck to engineer up to four enzymes for use as biocatalysts in Merck's active pharmaceutical ingredient (API) manufacturing efforts.
read more
Tuesday, October 11, 2022
Samsung Biologics announced that its Plant 4 has commenced GMP operations this month.
Plant 4's partial operations comes just 23 months after construction began in November 2020, adding fresh production capacity of 60,000 liters.
read more
Evonik entered into a long-term supply agreement with Phathom Pharmaceuticals. Through the agreement Evonik will produce large-scale volumes of vonoprazan at its FDA-inspected manufacturing sites in Tippecanoe, Indiana, USA and Dossenheim, Germany.
read more
Logistics4Pharma GmbH announced an expansion to it capabilities with a recent investment in ultra-deep-freeze (UDF) warehousing for temperatures as low as -80 Deg C that enables the storage of highly sensitive medicines such as proteins and COVID-19 ...
read more
Enzo Biochem announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York.
read more
Alimentiv, Satisfai Health, and Virgo Surgical Video Solutions announced a strategic partnership to revolutionize central reading, data capture, decision support, and patient recruitment in the clinical trial domain for Inflammatory Bowel Disease (...
read more
Dipharma Francis S.r.l. announced that the Italian Medicines Agency (AIFA) approved the brand-new production line at the cGMP pilot plant suite, located in its facility of Mereto di Tomba (Italy).
read more
Intravacc, has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the development of a ...
read more
Paradigm Clinical Research, with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical ...
read more